Modelling of Pharyngeal Laryngeal Effectiveness
Launched by UNIVERSITY HOSPITAL, TOULOUSE · Aug 22, 2023
Trial Information
Current as of November 14, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how well our throat and voice box work during swallowing, particularly for those with swallowing disorders. The researchers will use five non-invasive sensors (like a microphone and other simple devices) to gather information about swallowing, airway protection, and voice production. They aim to find reliable indicators that can help diagnose swallowing problems and assess their severity, which could lead to better treatment options.
To participate, patients must have a swallowing disorder and be able to follow up over the phone for six months. Healthy volunteers are also needed, but they must not have any swallowing difficulties. Throughout the study, participants can expect to undergo tests that monitor their swallowing and airway function, all while ensuring their comfort and safety. This research is important as it could help develop new, easier ways to diagnose and monitor swallowing disorders without invasive procedures.
Gender
ALL
Eligibility criteria
- Inclusion criteria for patients with swallowing disorders :
- • Indication to perform a swallowing test (suspected or proven swallowing disorder or presence of a complication)
- • Able to follow up by phone for 6 months or have a caregiver who can answer for them
- • Affiliated subject or beneficiary of the social security system
- • Consent to participate obtained in writing and signed by the subject or, if applicable, the next of kin/support person
- Inclusion criteria for healthy volunteers :
- • No swallowing disorder or discomfort (DHI score\<8)
- • Affiliated subject or beneficiary of the social security system
- • Signed Consent to Participate
- Non-inclusion criteria for patients with swallowing disorders :
- • Skin lesion(s) at the neck
- • Tracheotomy or tracheostomy (laryngectomy)
- • Nasogastric probe
- • Iodine allergy
- • Asthma
- • Refusal or any pathology incompatible with passing one of the two reference exams or the sensors used
- • Any serious pathology (severe health or behavioral disorders) where, according to the investigator, this could expose participants to additional risks
- • Legal protection (guardianship, curators, safeguarding of justice)
- • Pregnant and lactating women
- Non-inclusion criteria for healthy volunteers :
- • Medical history may result in chronic (history of oral-rhino-laryngeal cancer or neurological disease) or temporary (upper respiratory tract infections) swallowing impairment
- • Presence of swallowing disorder or discomfort (Deglutition Handicap Index score superior or equal to 8)
- • Skin lesion(s) at the neck
- • Tracheotomy or tracheostomy (laryngectomy)
- • Nasogastric probe
- • Iodine allergy
- • Asthma
- • Refusal or any pathology incompatible with passing one of the two reference exams or the sensors used
- • Any serious pathology (severe health or behavioral disorders) where, according to the investigator, this could expose participants to additional risks
- • Legal protection (guardianship, curators, safeguarding of justice)
- • Pregnant and lactating women
About University Hospital, Toulouse
The University Hospital of Toulouse is a leading academic medical center dedicated to advancing healthcare through innovative research and clinical trials. With a strong emphasis on patient-centered care, the hospital integrates cutting-edge scientific inquiry with comprehensive clinical services. Its multidisciplinary team of healthcare professionals collaborates with renowned researchers to facilitate pioneering studies across various medical fields, aiming to enhance treatment options and improve patient outcomes. As a prominent institution in the region, the University Hospital of Toulouse is committed to fostering an environment of excellence in both education and research within the healthcare community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bordeaux, France
Tours, France
Toulouse, France
Rouen, France
Bordeaux, France
Patients applied
Trial Officials
Virginie WOISARD, MD
Principal Investigator
University Hospital of Toulouse
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported